The US Food and Drug Administration (FDA) has approved Gilead Sciences’ expensive antiviral drug remdesivir to treat Covid-19, expanding its earlier emergency use authorization and guaranteeing huge profits for the company.
Remdesivir has become the first and only drug to be officially approved in the US for treating...
FDA Approves Antiviral Remdesivir As COVID-19 Treatment
Eurasia Review
0 shares
1 views
You might like
Related news coverage
New COVID-19 Cases And Hospitalizations Up; Deaths May Follow
Newsy
Watch VideoHospitals are bracing for another surge of COVID-19 patients. In parts of Texas, COVID-19 hospitalizations have roughly..
-
Supreme Court takes into account WHO report on Remdesivir, seeks Centre's response
Mid-Day
-
Gilead Sales Up 18% in Q3, Thanks to Coronavirus Treatment Remdesivir
Motley Fool
-
United States: FDA Approves Veklury (Remdesivir) As The First Treatment For COVID-19 - Seyfarth Shaw LLP
Mondaq
-
NA Proactive news snapshot: Revive Therapeutics, KULR Technology, Lexaria Bioscience, TRACON Pharmaceuticals UPDATE …
Proactive Investors
Advertisement
More coverage
Manjunath advocates use of remdesivir in treatment
Hindu
He emphasises that the antiviral drug should be administered to COVID-19 patients before they turn extremely sick
-
NA Proactive news snapshot: KWESST Micro Systems, WeedMD, Bragg Gaming Group, MGX Minerals, Phunware, Nextleaf Solutions, Candelaria Mining UPDATE…
Proactive Investors
-
NA Proactive news snapshot: Esports Entertainment Group, CytoDyn, ImagineAR, GlobeX Data …
Proactive Investors
-
Biotech Stocks Facing FDA Decision In November 2020
RTTNews
-
US stocks end mixed as investors weigh coronavirus stimulus package negotiations
Proactive Investors